Federated Hermes’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.41K Buy
+186
New +$4.64K ﹤0.01% 1924
2025
Q2
– Sell
-15
Closed -$178 – 2150
2025
Q1
$178 Sell
15
-22,625
-100% -$378K ﹤0.01% 2041
2024
Q4
$427K Sell
22,640
-19,564
-46% -$448K ﹤0.01% 1353
2024
Q3
$948K Buy
+42,204
New +$956K ﹤0.01% 1135

Other funds holding NRIX

Federated Hermes's NRIX Position: Q3 2026 in Review

Federated Hermes opened a new position in Nurix Therapeutics (NRIX) in Q3 2026: 186 shares worth $4.41K. The stake represents ﹤0.01% of the portfolio and ranks #1924 among its holdings. This is a return to the name: Federated Hermes previously reported a position in NRIX as recently as Q1 2025.

Federated Hermes first reported a position in NRIX in Q3 2024 and has held it in 4 quarters since. The position peaked at $948K in Q3 2024. 233 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.

  • Federated Hermes held 186 shares of Nurix Therapeutics worth $4.41K as of Q3 2026.
  • Nurix Therapeutics was a new Federated Hermes position in Q3 2026.
  • Nurix Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q3 2026, its #1924 holding.
  • Federated Hermes first reported a position in Nurix Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • Federated Hermes's Nurix Therapeutics position peaked at $948K in Q3 2024.
  • 233 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.

Based on Federated Hermes's 13F filing for Q3 2026, filed 12 Nov 2026.